Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 21,924,119	$ 28,094,936
Prepaid assets and other current assets	610,376	1,092,462
Total assets	22,534,495	29,187,398
Current liabilities:
Accounts payable	689,803	410,638
Total current liabilities	689,803	410,638
Accrued research and development expense (see Note 5)		1,132,013
Total liabilities	689,803	1,542,651
Stockholders’ equity:
Common stock; $0.001 par value, 45,000,000 shares authorized; 18,671,658 and 18,450,992 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	18,672	18,451
Additional paid-in capital	45,191,702	43,338,710
Accumulated other comprehensive loss	(39,491)
Accumulated deficit	(23,326,191)	(15,712,414)
Total stockholders’ equity	21,844,692	27,644,747
Total liabilities and stockholders’ equity	$ 22,534,495	$ 29,187,398